Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection

Annals of Pharmacotherapy

Volumn 42, Issue 4, 2008, Pages 592-593

  Moise, Pamela A ^a,b   Castro, Rochelle S ^a   Sul, Caroline ^b   Forrest, Alan ^c   Sakoulas, George ^d,e  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID;

ADULT; AGED; ERADICATION THERAPY; FISHER EXACT TEST; HUMAN; KAPLAN MEIER METHOD; KRUSKAL WALLIS TEST; LETTER; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION;

ACETAMIDES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 42049110559     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K613     Document Type: Letter

References (5)

1. Kelly S, Collins J, Davin M, Gowing C, Murphy PG. Linezolid resistance in coagulase negative staphylococci. J Antimicrob Chemother 2006; 58:898-9; author reply 899-900.
2. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007;60:788-94.
3. Andes D, van Ogtrop ML, Peng J, Craig WA. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother 2002;46:3484-9.
4. Gee T, Ellis R, Marshall G, et al. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother 2001;45:1843-6.
5. Moise PA, Forrest A, Birmingham MC, Schentag JJ. The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin. J Antimicrob Chemother 2002;50:1017-26.